Tired of slow Windows 11 search? Discover six powerful tools that replace it with speed, custom triggers, AI features, and full control.

Biogen has started a phase 3 trial that it hopes will extend the label for its Skyclarys therapy for inherited neurological disease Friedreich's ataxia (FA) to include children as young as two.